Table of Contents
- 1 Aromasin 30x25mg
- 2 Consequences
- 3 Aromasin can have serious adverse effects
- 4 Aromasin’s Services
- 5 Postmenopausal Women’s Adjuvant Treatment
- 6 AROMASIN is approved for postmenopausal women with estrogen-receptor positive early breast cancer who have completed two to three years of tamoxifen treatment and want to switch to AROMASIN for a total of five years of adjuvant hormonal therapy.
- 7 In advanced breast cancer in postmenopausal women
- 8 AROMASIN is a drug that is used to treat advanced breast cancer in postmenopausal women whose condition has worsened after tamoxifen therapy.
- 9 Dosage
- 10 Precautions
Aromasin 25mg is a medication that is used to treat breast cancer symptoms. Aromasin can be used on its own or in combination with other drugs. Aromasin is an Aromatase Inhibitor, which is an anti-cancer medication. Aromasin’s utility and safety in youngsters are still unknown.
Aromasin has the potential to induce the following side effects:
- Heat bursts
- an increased desire to consume
- issues with sleep (insomnia)
Aromasin can have serious adverse effects
- including new or atypical bone pain.
- Swelling in your hands or feet
- shortness of breath.
- weakness in the arms or legs
- severe migraine
- issues with vision, speech, or balance
If you experience a side effect that concerns you or does not go away, contact your doctor.Aromasin comes with a slew of negative side effects. These are only a couple of instances. Consult your doctor or pharmacist for more information. AROMASIN Tablets are steroidal aromatase inactivators that include 25 mg of exemestane. 6-Methylenandrosta-1,4-diene-3,17-dione is the chemical name for exemestane. C20H24O2 is its molecular formula. The active component is a crystalline powder that is white to slightly yellow in color and has a molecular weight of 296.41. Exemestane is soluble in N, N-dimethylformamide, methanol, and water, but it is practically insoluble in the latter. Mannitol, crospovidone, polysorbate 80, hypromellose, colloidal silicon dioxide, microcrystalline cellulose, sodium starch glycolate, magnesium stearate, simethicone, polyethylene glycol 6000, sucrose, magnesium carbonate, titanium dioxide, methylparaben, and polyvinyl alcohol are among the inactive ingredients in each AROMASIN Tablet.
Postmenopausal Women’s Adjuvant Treatment
AROMASIN is approved for postmenopausal women with estrogen-receptor positive early breast cancer who have completed two to three years of tamoxifen treatment and want to switch to AROMASIN for a total of five years of adjuvant hormonal therapy.
In advanced breast cancer in postmenopausal women
AROMASIN is a drug that is used to treat advanced breast cancer in postmenopausal women whose condition has worsened after tamoxifen therapy.
In early and advanced breast cancer, one 25 mg tablet taken once day after a meal is the recommended dose of AROMASIN. Before making any hurried decisions, contact your doctor if you feel your dose should be altered. Take the medicine as soon as possible, but if your next dosage is approaching, avoid the missed dose. Take no more than one dosage at a time. Before you run out of medication, have your prescription reissued. In the event of an overdose, seek medical attention right away.
If you’re allergic to exemestane, haven’t reached menopause, or are pregnant or planning to get pregnant, don’t use Aromasin. If you’re expecting a child, avoid using Aromasin. It has the potential to cause damage to a child while still in the womb. If you have liver or kidney problems, or if you haven’t reached menopause but are still experiencing menstrual cycles, talk to your doctor before using this medication. To get the most out of Aromasin, use it on a regular basis. Before you run out of medication, have your prescription reissued. This drug may be required for up to 5 years. Pay attention to your doctor’s advice. If you combine this medication with hormone replacement therapy, it’s probable that it won’t function as effectively.